Designing clinical trials to address the needs of childhood and adult asthma: the National Heart, Lung, and Blood Institute's AsthmaNet.
J Allergy Clin Immunol
; 133(1): 34-8.e1, 2014 Jan.
Article
en En
| MEDLINE
| ID: mdl-24369797
Palabras clave
APRIL; AVICA; Acetaminophen Vs. Ibuprofen in Children with Asthma; AsthmaNet; Azithromycin for Preventing the Development of Upper Respiratory Tract Illness into Lower Respiratory Tract Symptoms in Children; BADGER; BARD; Best Add-on Therapy Giving Effective Responses; Best African-American Response to Asthma Drugs; DCC; Data coordinating center; ICS; INFANT; Individualized Therapy for Asthma in Toddlers; Inhaled corticosteroid; NHLBI; NIH; National Heart, Lung, and Blood Institute; National Institutes of Health; OCELOT; Oral Corticosteroids for Treating Episodes of Significant Lower Respiratory Tract Symptoms in Children; PRC; Protocol Review Committee; RTI; Respiratory tract illness; SC; STICS; Steering Committee; Step-up Yellow Zone Inhaled Corticosteroids to Prevent Exacerbations; VIDA; Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma; asthma; asthma management; clinical trials; mechanistic studies; proof of concept; treatment
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Asma
/
Antiasmáticos
/
National Heart, Lung, and Blood Institute (U.S.)
/
Necesidades y Demandas de Servicios de Salud
Tipo de estudio:
Prognostic_studies
Límite:
Adult
/
Child
/
Humans
/
Male
País/Región como asunto:
America do norte
Idioma:
En
Revista:
J Allergy Clin Immunol
Año:
2014
Tipo del documento:
Article
Pais de publicación:
Estados Unidos